No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Specialties
Shanghai General Healthy Information and Technology Co., Ltd. (SGHIT) delivers a range of advanced solutions to the healthcare sector in China. These encompass automated pharmaceutical logistics, cutting-edge information technology, and intelligent, mobile medical applications. Its core product portfolio features the "Smart Pharmacy Project," an integrated hardware and software system designed for intelligent medication management. Another key offering is the "Intelligent Static Distribution Center Project," a sophisticated system for the configuration and oversight of intravenous medications. Additionally, the "Intelligent Drug Consumables Management Project" provides specialized oversight for various pharmaceutical supplies, including controlled substances and high-value medical items. Established in 2014, SGHIT operates from its headquarters in Shanghai, China.
www.g-healthy.comNo one on the platform currently holds 605186.SS.
No tracked institution reports a position in 605186.SS as of their last filing.
No one on the platform has traded 605186.SS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 2.5% | 12.1% | 80.5% | — | — | — |
| Rev. Growth % | 8.5% | 3.8% | ||||
| Profit Margin % | 8.9% | 19.7% | 22.4% | |||
| Free Cash Flow Margin % | 20.9% | -15.6% | -1.4% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $383M | -7.1% | $0.50 | $0.50–$0.50 | — | 1 |
| 2027 | $422M | +10.2% | $0.62 | $0.62–$0.62 | — | 1 |
| 2028 | $460M | +9.2% | $0.75 | $0.75–$0.75 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 605186.SSShanghai General Healthy Information and Technology Co., Ltd. | $25.12 | +0.76% | $3.4B | — |
| 002022.SZShanghai Kehua Bio-engineering Co., Ltd. | $5.56 | +0.18% | $2.9B | — |
| 002589.SZRealcan Pharmaceutical Group Co., Ltd. | $2.95 | +0.34% | $3.9B | — |
| 300246.SZGuangdong Biolight Meditech Co., Ltd. | $14.96 | +2.12% | $4.0B | — |
| 300562.SZGuangdong Transtek Medical Electronics Co., Ltd |
| $16.62 |
| -0.72% |
| $3.6B |
| — |
| 600833.SSShanghai No.1 Pharmacy Co., Ltd. | $10.13 | +0.10% | $2.3B | — |
| 605266.SSJianzhijia Pharmaceutical Chain Group Co., Ltd. | $15.18 | -0.26% | $2.3B | — |
Source: Financial Modeling Prep · peers by sector/industry